| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotherapy | 85 | 2024 | 1646 | 12.140 |
Why?
|
| Anxiety | 47 | 2024 | 4569 | 6.700 |
Why?
|
| Depression | 60 | 2024 | 8132 | 6.330 |
Why?
|
| Anxiety Disorders | 52 | 2024 | 2723 | 5.380 |
Why?
|
| Depressive Disorder | 35 | 2024 | 3727 | 3.820 |
Why?
|
| Conduct Disorder | 12 | 2024 | 245 | 3.720 |
Why?
|
| Child Behavior Disorders | 34 | 2023 | 804 | 2.760 |
Why?
|
| Mental Disorders | 50 | 2024 | 6823 | 2.600 |
Why?
|
| Mental Health | 20 | 2024 | 3251 | 2.410 |
Why?
|
| Community Mental Health Services | 18 | 2020 | 387 | 2.400 |
Why?
|
| Adolescent | 218 | 2024 | 88300 | 2.340 |
Why?
|
| Evidence-Based Practice | 13 | 2020 | 493 | 2.280 |
Why?
|
| Internal-External Control | 26 | 2017 | 358 | 2.150 |
Why?
|
| Child Behavior | 10 | 2019 | 848 | 2.040 |
Why?
|
| Psychometrics | 28 | 2022 | 3061 | 1.880 |
Why?
|
| Cross-Cultural Comparison | 24 | 2021 | 634 | 1.860 |
Why?
|
| Kenya | 20 | 2024 | 756 | 1.800 |
Why?
|
| Child | 199 | 2024 | 80154 | 1.790 |
Why?
|
| Parents | 21 | 2023 | 3564 | 1.690 |
Why?
|
| Parent-Child Relations | 16 | 2018 | 762 | 1.670 |
Why?
|
| Behavioral Symptoms | 3 | 2021 | 186 | 1.650 |
Why?
|
| Child of Impaired Parents | 4 | 2019 | 460 | 1.400 |
Why?
|
| Mental Health Services | 14 | 2022 | 1716 | 1.350 |
Why?
|
| Psychotherapy, Brief | 4 | 2020 | 118 | 1.300 |
Why?
|
| Adolescent Behavior | 9 | 2017 | 1188 | 1.280 |
Why?
|
| Models, Psychological | 10 | 2016 | 830 | 1.240 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 6 | 2020 | 306 | 1.180 |
Why?
|
| Randomized Controlled Trials as Topic | 19 | 2023 | 10218 | 1.140 |
Why?
|
| Motivation | 8 | 2020 | 2002 | 1.080 |
Why?
|
| Professional-Patient Relations | 5 | 2019 | 723 | 1.070 |
Why?
|
| Referral and Consultation | 14 | 2020 | 3608 | 1.060 |
Why?
|
| Adolescent Psychiatry | 3 | 2020 | 156 | 1.020 |
Why?
|
| Estrogens, Catechol | 19 | 2000 | 25 | 0.990 |
Why?
|
| Personality | 4 | 2017 | 553 | 0.980 |
Why?
|
| Humans | 316 | 2024 | 761222 | 0.950 |
Why?
|
| Emotions | 6 | 2023 | 2742 | 0.950 |
Why?
|
| Child Psychiatry | 4 | 2015 | 227 | 0.940 |
Why?
|
| Parenting | 8 | 2016 | 701 | 0.930 |
Why?
|
| Irritable Mood | 3 | 2022 | 193 | 0.930 |
Why?
|
| Family Relations | 2 | 2016 | 317 | 0.830 |
Why?
|
| Male | 221 | 2024 | 360703 | 0.820 |
Why?
|
| Female | 238 | 2024 | 392552 | 0.820 |
Why?
|
| Psychotherapy, Group | 3 | 2021 | 413 | 0.790 |
Why?
|
| Adolescent Health Services | 5 | 2015 | 218 | 0.770 |
Why?
|
| Health Personnel | 6 | 2020 | 3337 | 0.760 |
Why?
|
| Adaptation, Psychological | 11 | 2017 | 2632 | 0.760 |
Why?
|
| Antisocial Personality Disorder | 3 | 2014 | 224 | 0.750 |
Why?
|
| Treatment Outcome | 54 | 2024 | 64681 | 0.740 |
Why?
|
| Caregivers | 5 | 2022 | 2244 | 0.740 |
Why?
|
| Evidence-Based Medicine | 12 | 2020 | 3691 | 0.690 |
Why?
|
| Allied Health Personnel | 1 | 2021 | 154 | 0.680 |
Why?
|
| Fluoxetine | 3 | 2021 | 728 | 0.680 |
Why?
|
| Feminism | 1 | 2019 | 6 | 0.660 |
Why?
|
| Family Therapy | 3 | 2016 | 214 | 0.640 |
Why?
|
| Health Services Research | 6 | 2020 | 1807 | 0.640 |
Why?
|
| Self Disclosure | 2 | 2019 | 249 | 0.640 |
Why?
|
| Personality Assessment | 13 | 2009 | 649 | 0.620 |
Why?
|
| Cytochrome P-450 CYP1A1 | 9 | 1992 | 89 | 0.610 |
Why?
|
| Peer Group | 2 | 2019 | 691 | 0.600 |
Why?
|
| Psychological Theory | 4 | 2016 | 176 | 0.600 |
Why?
|
| Psychiatric Status Rating Scales | 11 | 2016 | 6011 | 0.560 |
Why?
|
| Reproducibility of Results | 26 | 2023 | 20118 | 0.560 |
Why?
|
| Steroid Hydroxylases | 9 | 1992 | 93 | 0.560 |
Why?
|
| Research Design | 12 | 2022 | 6180 | 0.550 |
Why?
|
| Behavior Therapy | 8 | 2021 | 875 | 0.540 |
Why?
|
| Depression, Postpartum | 1 | 2021 | 349 | 0.530 |
Why?
|
| Mental Competency | 1 | 2017 | 178 | 0.530 |
Why?
|
| Estradiol | 30 | 1998 | 1937 | 0.520 |
Why?
|
| Interpersonal Relations | 3 | 2019 | 1437 | 0.520 |
Why?
|
| Community Mental Health Centers | 7 | 2013 | 93 | 0.520 |
Why?
|
| Social Environment | 6 | 2022 | 1022 | 0.520 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2021 | 3707 | 0.510 |
Why?
|
| Depressive Disorder, Major | 6 | 2021 | 4767 | 0.490 |
Why?
|
| Manuals as Topic | 3 | 2011 | 99 | 0.480 |
Why?
|
| Professional Practice | 1 | 2017 | 313 | 0.480 |
Why?
|
| Interview, Psychological | 6 | 2015 | 809 | 0.450 |
Why?
|
| Affective Symptoms | 6 | 1997 | 417 | 0.450 |
Why?
|
| Social Stigma | 2 | 2022 | 770 | 0.440 |
Why?
|
| Self Report | 5 | 2019 | 3727 | 0.430 |
Why?
|
| Developing Countries | 3 | 2022 | 2863 | 0.410 |
Why?
|
| Stress Disorders, Post-Traumatic | 5 | 2022 | 4575 | 0.410 |
Why?
|
| Patient Dropouts | 5 | 2017 | 411 | 0.390 |
Why?
|
| Autistic Disorder | 1 | 2021 | 1222 | 0.390 |
Why?
|
| Thailand | 14 | 2009 | 287 | 0.380 |
Why?
|
| Catechol O-Methyltransferase | 7 | 2000 | 251 | 0.380 |
Why?
|
| Dominance, Cerebral | 5 | 1999 | 623 | 0.380 |
Why?
|
| Research | 5 | 2017 | 1976 | 0.360 |
Why?
|
| Norway | 2 | 2024 | 499 | 0.360 |
Why?
|
| Social Control, Informal | 1 | 2010 | 44 | 0.350 |
Why?
|
| Aggression | 6 | 2003 | 748 | 0.350 |
Why?
|
| Factor Analysis, Statistical | 6 | 2015 | 998 | 0.340 |
Why?
|
| School Health Services | 3 | 2020 | 384 | 0.340 |
Why?
|
| Child Health Services | 6 | 2020 | 644 | 0.340 |
Why?
|
| Mother-Child Relations | 4 | 2021 | 495 | 0.340 |
Why?
|
| Luteinizing Hormone | 15 | 1989 | 820 | 0.340 |
Why?
|
| Decision Trees | 1 | 2011 | 505 | 0.330 |
Why?
|
| Cost-Benefit Analysis | 3 | 2023 | 5493 | 0.330 |
Why?
|
| Meta-Analysis as Topic | 6 | 2015 | 1381 | 0.330 |
Why?
|
| Tretinoin | 2 | 2002 | 517 | 0.320 |
Why?
|
| Ego | 2 | 2000 | 98 | 0.320 |
Why?
|
| Breast | 4 | 2003 | 1964 | 0.320 |
Why?
|
| Stress, Psychological | 8 | 2016 | 4487 | 0.320 |
Why?
|
| Hypothalamus | 15 | 1986 | 999 | 0.320 |
Why?
|
| Schools | 4 | 2022 | 1483 | 0.320 |
Why?
|
| Family Characteristics | 1 | 2014 | 992 | 0.310 |
Why?
|
| Patient Compliance | 4 | 2023 | 2688 | 0.310 |
Why?
|
| NADP | 11 | 1998 | 227 | 0.300 |
Why?
|
| Ambulatory Care | 6 | 2016 | 2770 | 0.300 |
Why?
|
| Psychological Tests | 5 | 2004 | 639 | 0.290 |
Why?
|
| Adult | 67 | 2023 | 221120 | 0.290 |
Why?
|
| Juvenile Delinquency | 5 | 2010 | 116 | 0.280 |
Why?
|
| Estrogens | 7 | 2000 | 1522 | 0.280 |
Why?
|
| Clinical Competence | 3 | 2021 | 4788 | 0.280 |
Why?
|
| Child Development | 12 | 2000 | 2302 | 0.280 |
Why?
|
| Attitude | 7 | 2018 | 771 | 0.270 |
Why?
|
| Decision Making | 3 | 2022 | 3931 | 0.270 |
Why?
|
| Microsomes | 6 | 1998 | 251 | 0.270 |
Why?
|
| Ambulatory Care Facilities | 2 | 2023 | 934 | 0.270 |
Why?
|
| Health Services Needs and Demand | 3 | 2011 | 1401 | 0.260 |
Why?
|
| Telemedicine | 2 | 2023 | 3051 | 0.260 |
Why?
|
| Cytochrome P-450 Enzyme System | 7 | 1998 | 413 | 0.260 |
Why?
|
| Culture | 2 | 2000 | 623 | 0.260 |
Why?
|
| Income | 1 | 2015 | 1869 | 0.260 |
Why?
|
| Chronic Disease | 2 | 2020 | 9319 | 0.260 |
Why?
|
| Clinical Protocols | 6 | 2018 | 1436 | 0.260 |
Why?
|
| Child Abuse | 2 | 2006 | 1076 | 0.260 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 2493 | 0.260 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2576 | 0.260 |
Why?
|
| Mood Disorders | 2 | 2020 | 1124 | 0.250 |
Why?
|
| Glucosephosphate Dehydrogenase | 7 | 1992 | 209 | 0.250 |
Why?
|
| Residential Treatment | 1 | 2006 | 111 | 0.250 |
Why?
|
| Aromatase | 5 | 1996 | 147 | 0.250 |
Why?
|
| Attitude to Health | 4 | 2017 | 2026 | 0.250 |
Why?
|
| Needs Assessment | 1 | 2011 | 1141 | 0.250 |
Why?
|
| Alcohol Dehydrogenase | 2 | 2003 | 113 | 0.240 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2017 | 265 | 0.240 |
Why?
|
| Hydroxyestrones | 3 | 2002 | 17 | 0.240 |
Why?
|
| Child, Preschool | 26 | 2021 | 42225 | 0.230 |
Why?
|
| Glucuronosyltransferase | 2 | 2002 | 132 | 0.230 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2004 | 31 | 0.230 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 6 | 1990 | 34 | 0.230 |
Why?
|
| Functional Laterality | 4 | 2001 | 2257 | 0.230 |
Why?
|
| Ovary | 17 | 1987 | 957 | 0.230 |
Why?
|
| Rheumatic Fever | 1 | 2004 | 73 | 0.220 |
Why?
|
| Testosterone | 22 | 1994 | 2472 | 0.220 |
Why?
|
| Cultural Characteristics | 2 | 2006 | 250 | 0.220 |
Why?
|
| Guideline Adherence | 4 | 2021 | 2220 | 0.220 |
Why?
|
| Object Attachment | 3 | 2001 | 326 | 0.220 |
Why?
|
| Social Adjustment | 5 | 2000 | 632 | 0.220 |
Why?
|
| Expressed Emotion | 1 | 2004 | 92 | 0.220 |
Why?
|
| Benchmarking | 2 | 2017 | 1045 | 0.220 |
Why?
|
| Oxidoreductases | 7 | 1984 | 411 | 0.220 |
Why?
|
| Violence | 3 | 2017 | 935 | 0.210 |
Why?
|
| Combined Modality Therapy | 5 | 2020 | 8519 | 0.210 |
Why?
|
| Vision, Monocular | 2 | 1994 | 71 | 0.210 |
Why?
|
| Leydig Cells | 7 | 1990 | 55 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 7400 | 0.210 |
Why?
|
| Follow-Up Studies | 15 | 2022 | 39127 | 0.200 |
Why?
|
| Pressoreceptors | 2 | 2002 | 99 | 0.200 |
Why?
|
| Biomedical Research | 2 | 2015 | 3434 | 0.200 |
Why?
|
| Loneliness | 2 | 2022 | 203 | 0.200 |
Why?
|
| Attitude of Health Personnel | 3 | 2013 | 3885 | 0.200 |
Why?
|
| Family | 7 | 2014 | 3192 | 0.200 |
Why?
|
| Visual Perception | 4 | 1994 | 1386 | 0.200 |
Why?
|
| Visceral Afferents | 1 | 2001 | 9 | 0.200 |
Why?
|
| Carotid Sinus | 1 | 2001 | 44 | 0.200 |
Why?
|
| Sex Factors | 13 | 2015 | 10553 | 0.190 |
Why?
|
| Personality Inventory | 5 | 2010 | 1018 | 0.190 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 5 | 2016 | 1990 | 0.190 |
Why?
|
| Isoantigens | 1 | 2004 | 559 | 0.190 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2002 | 163 | 0.190 |
Why?
|
| Age Factors | 15 | 2015 | 18384 | 0.190 |
Why?
|
| Personality Development | 7 | 2001 | 243 | 0.180 |
Why?
|
| Verbal Behavior | 1 | 2002 | 335 | 0.180 |
Why?
|
| Antigens, CD19 | 1 | 2004 | 424 | 0.180 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 5333 | 0.180 |
Why?
|
| Tourette Syndrome | 1 | 2004 | 395 | 0.180 |
Why?
|
| Rats | 60 | 2000 | 23705 | 0.180 |
Why?
|
| Ethnopsychology | 1 | 2000 | 19 | 0.180 |
Why?
|
| Single-Blind Method | 2 | 2021 | 1577 | 0.180 |
Why?
|
| Baroreflex | 1 | 2001 | 149 | 0.180 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 748 | 0.180 |
Why?
|
| Pituitary Gland, Anterior | 5 | 1989 | 142 | 0.170 |
Why?
|
| Eye Movements | 3 | 1993 | 510 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2018 | 3200 | 0.170 |
Why?
|
| Antidepressive Agents | 5 | 2021 | 2893 | 0.170 |
Why?
|
| Maternal Behavior | 1 | 2002 | 307 | 0.170 |
Why?
|
| Happiness | 1 | 2021 | 170 | 0.170 |
Why?
|
| Tolmetin | 1 | 1999 | 24 | 0.170 |
Why?
|
| Psychology, Clinical | 2 | 1998 | 42 | 0.170 |
Why?
|
| Hawaii | 4 | 2013 | 101 | 0.170 |
Why?
|
| Young Adult | 11 | 2023 | 59222 | 0.170 |
Why?
|
| Heart Rate | 5 | 1994 | 4197 | 0.170 |
Why?
|
| Pseudophakia | 1 | 1999 | 60 | 0.170 |
Why?
|
| Endometrium | 1 | 2002 | 403 | 0.160 |
Why?
|
| Estrone | 11 | 1996 | 234 | 0.160 |
Why?
|
| Stress, Physiological | 6 | 1990 | 1405 | 0.160 |
Why?
|
| Microsomes, Liver | 6 | 1994 | 172 | 0.160 |
Why?
|
| Estradiol Congeners | 1 | 1998 | 23 | 0.160 |
Why?
|
| Thioacetamide | 2 | 1997 | 22 | 0.160 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2000 | 330 | 0.160 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 1992 | 244 | 0.160 |
Why?
|
| Dihydrotestosterone | 7 | 1979 | 195 | 0.160 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1999 | 138 | 0.150 |
Why?
|
| RNA, Messenger | 6 | 2004 | 12747 | 0.150 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1999 | 209 | 0.150 |
Why?
|
| Observer Variation | 5 | 2015 | 2610 | 0.150 |
Why?
|
| Vagina | 1 | 2004 | 841 | 0.150 |
Why?
|
| Testis | 8 | 1990 | 781 | 0.150 |
Why?
|
| Comorbidity | 3 | 2023 | 10516 | 0.150 |
Why?
|
| Mothers | 2 | 2013 | 2193 | 0.150 |
Why?
|
| Ethinyl Estradiol | 1 | 1998 | 113 | 0.150 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 1506 | 0.150 |
Why?
|
| Camping | 1 | 1997 | 13 | 0.150 |
Why?
|
| Progesterone | 8 | 1987 | 742 | 0.140 |
Why?
|
| Speech | 1 | 2002 | 554 | 0.140 |
Why?
|
| Macula Lutea | 1 | 1999 | 177 | 0.140 |
Why?
|
| Open Reading Frames | 1 | 2000 | 811 | 0.140 |
Why?
|
| Anxiety, Separation | 1 | 1997 | 86 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11101 | 0.140 |
Why?
|
| Rats, Inbred Strains | 15 | 1990 | 2087 | 0.140 |
Why?
|
| Affect | 2 | 2002 | 1486 | 0.140 |
Why?
|
| Computer Graphics | 1 | 1999 | 338 | 0.140 |
Why?
|
| Ethanol | 1 | 2003 | 1322 | 0.140 |
Why?
|
| Cell Transplantation | 1 | 1999 | 472 | 0.140 |
Why?
|
| Defense Mechanisms | 2 | 2016 | 180 | 0.140 |
Why?
|
| Severity of Illness Index | 8 | 2018 | 15841 | 0.140 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2019 | 489 | 0.130 |
Why?
|
| Attention | 7 | 1999 | 2394 | 0.130 |
Why?
|
| Aldehydes | 1 | 1997 | 170 | 0.130 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2003 | 1084 | 0.130 |
Why?
|
| Sequence Deletion | 1 | 2000 | 1487 | 0.130 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1992 | 476 | 0.130 |
Why?
|
| Evoked Potentials, Visual | 1 | 1999 | 417 | 0.130 |
Why?
|
| Self Concept | 3 | 1999 | 1046 | 0.130 |
Why?
|
| Therapeutics | 2 | 1995 | 113 | 0.130 |
Why?
|
| Androstanes | 6 | 1979 | 20 | 0.130 |
Why?
|
| Sampling Studies | 3 | 2005 | 615 | 0.130 |
Why?
|
| HLA-DR1 Antigen | 1 | 1995 | 11 | 0.130 |
Why?
|
| HLA-DR4 Antigen | 1 | 1995 | 22 | 0.130 |
Why?
|
| Breast Neoplasms | 7 | 2003 | 20982 | 0.130 |
Why?
|
| Students | 5 | 2024 | 1737 | 0.130 |
Why?
|
| Uveomeningoencephalitic Syndrome | 1 | 1995 | 22 | 0.120 |
Why?
|
| Macular Edema | 1 | 1999 | 374 | 0.120 |
Why?
|
| Social Values | 3 | 2006 | 225 | 0.120 |
Why?
|
| Diffusion of Innovation | 2 | 2012 | 730 | 0.120 |
Why?
|
| Kinetics | 18 | 1992 | 6312 | 0.120 |
Why?
|
| Cataract Extraction | 1 | 1999 | 463 | 0.120 |
Why?
|
| Checklist | 2 | 2013 | 828 | 0.120 |
Why?
|
| Universities | 1 | 2020 | 995 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2012 | 2425 | 0.120 |
Why?
|
| Tomography, Emission-Computed | 3 | 2002 | 1123 | 0.120 |
Why?
|
| Diagnosis | 1 | 1995 | 156 | 0.120 |
Why?
|
| Habits | 1 | 2015 | 147 | 0.120 |
Why?
|
| Galvanic Skin Response | 1 | 2016 | 358 | 0.120 |
Why?
|
| Analysis of Variance | 7 | 2011 | 6223 | 0.120 |
Why?
|
| Hemiplegia | 1 | 1995 | 136 | 0.120 |
Why?
|
| Sexual Behavior, Animal | 3 | 1984 | 120 | 0.120 |
Why?
|
| Fetus | 7 | 1989 | 1864 | 0.110 |
Why?
|
| Child Rearing | 3 | 1989 | 73 | 0.110 |
Why?
|
| Suicidal Ideation | 2 | 2022 | 1447 | 0.110 |
Why?
|
| Psychotropic Drugs | 1 | 1999 | 885 | 0.110 |
Why?
|
| Commitment of Mentally Ill | 2 | 1990 | 94 | 0.110 |
Why?
|
| Sick Role | 1 | 1994 | 229 | 0.110 |
Why?
|
| Cross-Sectional Studies | 9 | 2024 | 26072 | 0.110 |
Why?
|
| Health Promotion | 1 | 2005 | 2205 | 0.110 |
Why?
|
| Tissue Distribution | 6 | 2002 | 2263 | 0.110 |
Why?
|
| Sertraline | 1 | 2014 | 209 | 0.110 |
Why?
|
| Patient Satisfaction | 3 | 2020 | 3453 | 0.110 |
Why?
|
| Urban Population | 2 | 2011 | 2036 | 0.110 |
Why?
|
| Middle Aged | 21 | 2020 | 220858 | 0.110 |
Why?
|
| Multilevel Analysis | 1 | 2013 | 145 | 0.110 |
Why?
|
| Clinical Trials as Topic | 3 | 2004 | 8002 | 0.110 |
Why?
|
| Education, Continuing | 1 | 2013 | 114 | 0.100 |
Why?
|
| Professional Competence | 2 | 2012 | 430 | 0.100 |
Why?
|
| Estrus | 8 | 1984 | 70 | 0.100 |
Why?
|
| Los Angeles | 3 | 2003 | 244 | 0.100 |
Why?
|
| Taste | 2 | 2004 | 189 | 0.100 |
Why?
|
| Suicide | 1 | 2024 | 1602 | 0.100 |
Why?
|
| Animals | 84 | 2021 | 168089 | 0.100 |
Why?
|
| Public Health | 2 | 2023 | 2672 | 0.100 |
Why?
|
| Endometrial Neoplasms | 1 | 2002 | 1366 | 0.100 |
Why?
|
| Teaching | 4 | 1991 | 1171 | 0.100 |
Why?
|
| Prognosis | 4 | 2020 | 29688 | 0.100 |
Why?
|
| Oxidation-Reduction | 3 | 1997 | 2227 | 0.100 |
Why?
|
| Arousal | 3 | 1999 | 1171 | 0.100 |
Why?
|
| Subfornical Organ | 1 | 1992 | 10 | 0.100 |
Why?
|
| NADPH Dehydrogenase | 1 | 1992 | 44 | 0.100 |
Why?
|
| Electroencephalography | 5 | 2004 | 6242 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 1999 | 1393 | 0.100 |
Why?
|
| Risk Factors | 11 | 2022 | 74241 | 0.100 |
Why?
|
| Kidney | 5 | 1998 | 7033 | 0.100 |
Why?
|
| Individuality | 2 | 1993 | 303 | 0.100 |
Why?
|
| Social Work | 2 | 2013 | 157 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2000 | 1855 | 0.100 |
Why?
|
| Theft | 1 | 1991 | 20 | 0.100 |
Why?
|
| Forms and Records Control | 1 | 2012 | 158 | 0.100 |
Why?
|
| Immunohistochemistry | 7 | 2004 | 11067 | 0.100 |
Why?
|
| Granulosa Cells | 3 | 1986 | 115 | 0.100 |
Why?
|
| Fear | 1 | 2020 | 1477 | 0.090 |
Why?
|
| Enzyme Induction | 3 | 2003 | 452 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2881 | 0.090 |
Why?
|
| Macular Degeneration | 1 | 1999 | 1009 | 0.090 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 1982 | 370 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3594 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2001 | 2219 | 0.090 |
Why?
|
| Clinical Coding | 1 | 2012 | 181 | 0.090 |
Why?
|
| Faculty | 1 | 2014 | 383 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 1999 | 1510 | 0.090 |
Why?
|
| Outpatients | 1 | 2019 | 1598 | 0.090 |
Why?
|
| Personal Satisfaction | 1 | 2015 | 645 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2004 | 4744 | 0.090 |
Why?
|
| Concept Formation | 4 | 1995 | 161 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2014 | 2421 | 0.090 |
Why?
|
| Kidney Tubules, Proximal | 2 | 1998 | 382 | 0.090 |
Why?
|
| United States | 24 | 2017 | 72341 | 0.090 |
Why?
|
| Tritium | 11 | 1986 | 706 | 0.090 |
Why?
|
| Neurasthenia | 1 | 2009 | 16 | 0.090 |
Why?
|
| Awareness | 1 | 1994 | 649 | 0.090 |
Why?
|
| Cerebral Infarction | 1 | 1995 | 981 | 0.080 |
Why?
|
| Community Networks | 1 | 2011 | 202 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 2270 | 0.080 |
Why?
|
| Mental Processes | 1 | 1991 | 244 | 0.080 |
Why?
|
| Japan | 4 | 2001 | 1378 | 0.080 |
Why?
|
| Sex Differentiation | 4 | 1984 | 73 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 4243 | 0.080 |
Why?
|
| Twins | 1 | 1991 | 340 | 0.080 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 1982 | 1146 | 0.080 |
Why?
|
| Gene Expression | 1 | 2002 | 7571 | 0.080 |
Why?
|
| Mesocricetus | 5 | 1998 | 252 | 0.080 |
Why?
|
| Elimination Disorders | 1 | 2008 | 1 | 0.080 |
Why?
|
| Anthropology, Cultural | 2 | 2008 | 102 | 0.080 |
Why?
|
| Choroid Plexus | 1 | 1992 | 240 | 0.080 |
Why?
|
| Ovulation | 6 | 1986 | 181 | 0.080 |
Why?
|
| Fixation, Ocular | 1 | 1990 | 242 | 0.080 |
Why?
|
| Immunoblotting | 3 | 2002 | 1644 | 0.080 |
Why?
|
| Perception | 2 | 2022 | 1198 | 0.080 |
Why?
|
| Androstane-3,17-diol | 2 | 1979 | 20 | 0.080 |
Why?
|
| Brain | 10 | 2002 | 27094 | 0.080 |
Why?
|
| Syndrome | 2 | 2006 | 3271 | 0.080 |
Why?
|
| Poverty | 1 | 2020 | 2691 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 2164 | 0.080 |
Why?
|
| Organizational Culture | 1 | 2012 | 509 | 0.080 |
Why?
|
| Thalamus | 1 | 1995 | 1046 | 0.080 |
Why?
|
| Gender Identity | 4 | 2020 | 766 | 0.080 |
Why?
|
| New England | 1 | 2011 | 1052 | 0.080 |
Why?
|
| Cognition | 3 | 2020 | 6988 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2019 | 3024 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2000 | 5103 | 0.070 |
Why?
|
| Pituitary Gland | 6 | 1981 | 634 | 0.070 |
Why?
|
| Fetal Blood | 4 | 1989 | 1348 | 0.070 |
Why?
|
| NAD | 6 | 2003 | 612 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2003 | 8531 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2706 | 0.070 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 3220 | 0.070 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2001 | 189 | 0.070 |
Why?
|
| New Zealand | 2 | 2020 | 358 | 0.070 |
Why?
|
| Fundus Oculi | 2 | 1999 | 557 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 4 | 1999 | 909 | 0.070 |
Why?
|
| Molecular Sequence Data | 6 | 2004 | 17598 | 0.070 |
Why?
|
| Hydroxylation | 3 | 1998 | 137 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 4413 | 0.070 |
Why?
|
| Tissue Extracts | 3 | 1977 | 139 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 13402 | 0.070 |
Why?
|
| Glutathione Transferase | 2 | 2000 | 564 | 0.070 |
Why?
|
| Quality of Health Care | 2 | 2019 | 4321 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2015 | 5250 | 0.070 |
Why?
|
| Somatoform Disorders | 1 | 2009 | 424 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 6 | 1981 | 726 | 0.070 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2004 | 283 | 0.070 |
Why?
|
| Prevalence | 4 | 2022 | 15721 | 0.070 |
Why?
|
| Liver | 4 | 2000 | 7512 | 0.060 |
Why?
|
| Kidney Tubules, Distal | 1 | 1985 | 42 | 0.060 |
Why?
|
| Organizational Innovation | 1 | 2009 | 538 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 12976 | 0.060 |
Why?
|
| Social Identification | 1 | 2006 | 108 | 0.060 |
Why?
|
| Histocytochemistry | 9 | 1985 | 697 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 15308 | 0.060 |
Why?
|
| Achievement | 3 | 1982 | 288 | 0.060 |
Why?
|
| Cricetinae | 5 | 1998 | 2412 | 0.060 |
Why?
|
| Workload | 1 | 2011 | 845 | 0.060 |
Why?
|
| Spectinomycin | 1 | 1984 | 9 | 0.060 |
Why?
|
| Endophthalmitis | 2 | 1999 | 260 | 0.060 |
Why?
|
| Norepinephrine | 3 | 1978 | 897 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1994 | 1549 | 0.060 |
Why?
|
| Empirical Research | 1 | 2005 | 120 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2002 | 4567 | 0.060 |
Why?
|
| Anorexia Nervosa | 2 | 2004 | 1361 | 0.060 |
Why?
|
| Disease Management | 1 | 2015 | 2507 | 0.060 |
Why?
|
| Kidney Neoplasms | 2 | 1998 | 4251 | 0.060 |
Why?
|
| Sierra Leone | 2 | 2015 | 169 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2003 | 3590 | 0.060 |
Why?
|
| Structure-Activity Relationship | 4 | 2000 | 3057 | 0.060 |
Why?
|
| Heart | 3 | 1994 | 4431 | 0.060 |
Why?
|
| California | 3 | 1999 | 1431 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 1988 | 731 | 0.060 |
Why?
|
| Ovarian Follicle | 4 | 1986 | 244 | 0.060 |
Why?
|
| Reference Values | 4 | 2009 | 4921 | 0.060 |
Why?
|
| Birds | 1 | 1984 | 168 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 1994 | 695 | 0.060 |
Why?
|
| Stereotyping | 1 | 1985 | 239 | 0.060 |
Why?
|
| Preoptic Area | 1 | 1984 | 132 | 0.060 |
Why?
|
| Fluorescein Angiography | 2 | 1999 | 1062 | 0.050 |
Why?
|
| Pregnancy Complications | 3 | 1989 | 2949 | 0.050 |
Why?
|
| Castration | 3 | 1979 | 150 | 0.050 |
Why?
|
| Subcellular Fractions | 4 | 1998 | 524 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 1985 | 448 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 5783 | 0.050 |
Why?
|
| Peroxides | 2 | 1998 | 74 | 0.050 |
Why?
|
| Visual Fields | 1 | 1990 | 1061 | 0.050 |
Why?
|
| Intelligence | 3 | 1978 | 922 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2005 | 2489 | 0.050 |
Why?
|
| Hydrogen | 1 | 1984 | 172 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 9567 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 1992 | 2478 | 0.050 |
Why?
|
| Corticosterone | 1 | 1984 | 301 | 0.050 |
Why?
|
| Vulvovaginitis | 1 | 2003 | 14 | 0.050 |
Why?
|
| Hydroxysteroid Dehydrogenases | 5 | 1975 | 29 | 0.050 |
Why?
|
| Propiophenones | 2 | 1982 | 28 | 0.050 |
Why?
|
| Observation | 1 | 2005 | 310 | 0.050 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1990 | 461 | 0.050 |
Why?
|
| Patient Care Planning | 1 | 2008 | 901 | 0.050 |
Why?
|
| Suicide, Attempted | 2 | 2022 | 1402 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 2 | 1999 | 824 | 0.050 |
Why?
|
| Androstenedione | 5 | 1979 | 131 | 0.050 |
Why?
|
| Adrenal Glands | 4 | 1989 | 552 | 0.050 |
Why?
|
| Demography | 2 | 2006 | 1641 | 0.050 |
Why?
|
| Drug Resistance, Fungal | 1 | 2003 | 76 | 0.050 |
Why?
|
| Pregnancy | 22 | 2003 | 29893 | 0.050 |
Why?
|
| Oxygen Radioisotopes | 1 | 2002 | 75 | 0.050 |
Why?
|
| Blastocyst | 1 | 1985 | 432 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2004 | 293 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2015 | 2278 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14610 | 0.050 |
Why?
|
| Fluconazole | 1 | 2003 | 156 | 0.050 |
Why?
|
| Psychology | 2 | 2015 | 356 | 0.050 |
Why?
|
| Pharyngitis | 1 | 2004 | 220 | 0.050 |
Why?
|
| Massachusetts | 2 | 2013 | 8837 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 2 | 2002 | 2725 | 0.050 |
Why?
|
| Hospitals, University | 1 | 2003 | 565 | 0.050 |
Why?
|
| Control Groups | 1 | 2021 | 104 | 0.050 |
Why?
|
| Educational Status | 1 | 2009 | 2510 | 0.050 |
Why?
|
| Hypothalamus, Middle | 2 | 1979 | 15 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 2004 | 0.050 |
Why?
|
| Endometrial Hyperplasia | 1 | 2002 | 97 | 0.050 |
Why?
|
| Psychopathology | 2 | 2021 | 432 | 0.050 |
Why?
|
| Time Factors | 15 | 2015 | 39957 | 0.050 |
Why?
|
| Epithelium | 2 | 2004 | 1603 | 0.050 |
Why?
|
| trans-Golgi Network | 1 | 2000 | 33 | 0.050 |
Why?
|
| Dehydration | 2 | 1993 | 216 | 0.050 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2003 | 258 | 0.050 |
Why?
|
| Carbon Radioisotopes | 4 | 1992 | 562 | 0.050 |
Why?
|
| Visual Acuity | 3 | 1999 | 2676 | 0.050 |
Why?
|
| Human Development | 1 | 1982 | 123 | 0.050 |
Why?
|
| Embryonic Development | 1 | 1985 | 719 | 0.040 |
Why?
|
| Missouri | 1 | 2000 | 115 | 0.040 |
Why?
|
| Base Pairing | 1 | 2000 | 139 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
| Rural Population | 1 | 1991 | 2277 | 0.040 |
Why?
|
| Chlorides | 1 | 2003 | 657 | 0.040 |
Why?
|
| Pain | 1 | 1995 | 5072 | 0.040 |
Why?
|
| Socialization | 1 | 2000 | 87 | 0.040 |
Why?
|
| North Carolina | 2 | 1991 | 324 | 0.040 |
Why?
|
| Periodicity | 1 | 2001 | 347 | 0.040 |
Why?
|
| Candidiasis | 1 | 2003 | 365 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2359 | 0.040 |
Why?
|
| Vitamin A | 1 | 2003 | 612 | 0.040 |
Why?
|
| Forecasting | 3 | 2005 | 2928 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2001 | 517 | 0.040 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2001 | 241 | 0.040 |
Why?
|
| Cats | 1 | 2021 | 974 | 0.040 |
Why?
|
| Rabbits | 5 | 1986 | 4750 | 0.040 |
Why?
|
| Candida albicans | 1 | 2003 | 372 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2003 | 2820 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2003 | 3671 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 459 | 0.040 |
Why?
|
| Acute Disease | 2 | 2015 | 7226 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 7804 | 0.040 |
Why?
|
| Animals, Newborn | 5 | 1989 | 2665 | 0.040 |
Why?
|
| Learning | 2 | 2002 | 1737 | 0.040 |
Why?
|
| Streptococcal Infections | 1 | 2004 | 617 | 0.040 |
Why?
|
| Pregnancy, Animal | 1 | 1980 | 124 | 0.040 |
Why?
|
| Hospitalization | 4 | 2016 | 10707 | 0.040 |
Why?
|
| Toxoplasmosis | 1 | 1999 | 94 | 0.040 |
Why?
|
| Histological Techniques | 1 | 1999 | 193 | 0.040 |
Why?
|
| Colonic Diseases, Functional | 1 | 1999 | 39 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2004 | 1498 | 0.040 |
Why?
|
| Sulfotransferases | 1 | 2000 | 150 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 1979 | 87 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2000 | 1301 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2004 | 702 | 0.040 |
Why?
|
| Electrooculography | 1 | 1999 | 113 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 1980 | 387 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 4 | 1981 | 71 | 0.040 |
Why?
|
| Ketorolac | 1 | 1999 | 94 | 0.040 |
Why?
|
| Proestrus | 1 | 1978 | 14 | 0.040 |
Why?
|
| Morphine | 1 | 1983 | 656 | 0.040 |
Why?
|
| Radioimmunoassay | 6 | 1980 | 862 | 0.040 |
Why?
|
| Rats, Wistar | 4 | 1999 | 1848 | 0.040 |
Why?
|
| Acetylserotonin O-Methyltransferase | 1 | 1978 | 3 | 0.040 |
Why?
|
| Rorschach Test | 1 | 1978 | 26 | 0.040 |
Why?
|
| Kidney Cortex | 1 | 1998 | 168 | 0.040 |
Why?
|
| Eye Infections, Parasitic | 1 | 1998 | 26 | 0.040 |
Why?
|
| Patient Care Team | 2 | 2010 | 2515 | 0.040 |
Why?
|
| Pressure | 1 | 2001 | 1155 | 0.040 |
Why?
|
| Empiricism | 1 | 1998 | 7 | 0.040 |
Why?
|
| Myeloma Proteins | 1 | 1998 | 71 | 0.040 |
Why?
|
| Ophthalmic Solutions | 1 | 1999 | 311 | 0.040 |
Why?
|
| Guanylate Cyclase | 2 | 1995 | 205 | 0.040 |
Why?
|
| Seminiferous Tubules | 1 | 1977 | 25 | 0.040 |
Why?
|
| Deoxyribonuclease IV (Phage T4-Induced) | 1 | 1997 | 8 | 0.040 |
Why?
|
| Feedback | 3 | 1994 | 790 | 0.040 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 1979 | 112 | 0.040 |
Why?
|
| Uveitis, Anterior | 1 | 1998 | 101 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2003 | 752 | 0.040 |
Why?
|
| Lyases | 1 | 1997 | 42 | 0.040 |
Why?
|
| Character | 1 | 1997 | 27 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2000 | 609 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2000 | 563 | 0.040 |
Why?
|
| Paraproteinemias | 1 | 2000 | 250 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 1977 | 229 | 0.040 |
Why?
|
| Climate Change | 1 | 2024 | 498 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 848 | 0.040 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 1997 | 72 | 0.040 |
Why?
|
| Orientation | 1 | 1999 | 320 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1998 | 1053 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2020 | 8642 | 0.030 |
Why?
|
| Length of Stay | 1 | 1990 | 6417 | 0.030 |
Why?
|
| Pineal Gland | 1 | 1978 | 158 | 0.030 |
Why?
|
| Prolactin | 2 | 1978 | 625 | 0.030 |
Why?
|
| Normal Distribution | 1 | 1997 | 272 | 0.030 |
Why?
|
| 17-Ketosteroids | 2 | 1973 | 36 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1997 | 286 | 0.030 |
Why?
|
| Verbal Learning | 1 | 1999 | 463 | 0.030 |
Why?
|
| Polysorbates | 2 | 1986 | 44 | 0.030 |
Why?
|
| Adrenal Cortex | 1 | 1996 | 134 | 0.030 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 1996 | 56 | 0.030 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 1998 | 289 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 36415 | 0.030 |
Why?
|
| Postmenopause | 2 | 2003 | 2514 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 1981 | 3976 | 0.030 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 1996 | 29 | 0.030 |
Why?
|
| Videotape Recording | 1 | 1997 | 336 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2001 | 14675 | 0.030 |
Why?
|
| Delusions | 1 | 1998 | 298 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2004 | 1356 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 1518 | 0.030 |
Why?
|
| Aptitude | 2 | 1991 | 43 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1996 | 253 | 0.030 |
Why?
|
| Problem Solving | 2 | 1990 | 443 | 0.030 |
Why?
|
| Hydroxybutyrate Dehydrogenase | 1 | 1975 | 7 | 0.030 |
Why?
|
| Psychophysiology | 2 | 1999 | 135 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 1998 | 593 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2002 | 1416 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 1078 | 0.030 |
Why?
|
| Central America | 1 | 1995 | 69 | 0.030 |
Why?
|
| Social Work, Psychiatric | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1996 | 383 | 0.030 |
Why?
|
| Cerebral Cortex | 2 | 1990 | 5775 | 0.030 |
Why?
|
| Goals | 1 | 2000 | 710 | 0.030 |
Why?
|
| Pregnanes | 2 | 1971 | 7 | 0.030 |
Why?
|
| X-Ray Diffraction | 2 | 1988 | 418 | 0.030 |
Why?
|
| Methyltransferases | 1 | 1978 | 364 | 0.030 |
Why?
|
| Linear Models | 2 | 2012 | 5869 | 0.030 |
Why?
|
| Algorithms | 2 | 2015 | 14025 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2000 | 1404 | 0.030 |
Why?
|
| Nociceptors | 1 | 1999 | 460 | 0.030 |
Why?
|
| Prednisolone | 1 | 1996 | 324 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 169292 | 0.030 |
Why?
|
| Private Practice | 1 | 1995 | 152 | 0.030 |
Why?
|
| Blindness | 1 | 1999 | 586 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 1988 | 543 | 0.030 |
Why?
|
| Lysosomes | 1 | 1980 | 921 | 0.030 |
Why?
|
| Stimulation, Chemical | 4 | 1975 | 306 | 0.030 |
Why?
|
| Helplessness, Learned | 2 | 1985 | 28 | 0.030 |
Why?
|
| Dwarfism | 1 | 1975 | 137 | 0.030 |
Why?
|
| Focus Groups | 1 | 2020 | 1413 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 781 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2740 | 0.030 |
Why?
|
| Pentobarbital | 2 | 1973 | 153 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 1994 | 155 | 0.030 |
Why?
|
| Gestational Age | 5 | 1990 | 3580 | 0.030 |
Why?
|
| Association Learning | 1 | 1975 | 221 | 0.030 |
Why?
|
| Androgens | 3 | 1973 | 1283 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3778 | 0.030 |
Why?
|
| Atrophy | 1 | 1999 | 1633 | 0.030 |
Why?
|
| Program Development | 1 | 2020 | 1294 | 0.030 |
Why?
|
| Sleep Deprivation | 1 | 2020 | 847 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 1995 | 716 | 0.030 |
Why?
|
| Ovarian Cysts | 2 | 1971 | 108 | 0.030 |
Why?
|
| Pituitary Gland, Posterior | 1 | 1993 | 42 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1983 | 2517 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 1998 | 7571 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5871 | 0.030 |
Why?
|
| India | 1 | 2020 | 2287 | 0.030 |
Why?
|
| Swine | 4 | 1987 | 5909 | 0.030 |
Why?
|
| Eye Infections, Bacterial | 1 | 1996 | 241 | 0.030 |
Why?
|
| Fadrozole | 1 | 1992 | 3 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2203 | 0.030 |
Why?
|
| Mexico | 1 | 1995 | 757 | 0.030 |
Why?
|
| Infant | 6 | 2001 | 36170 | 0.030 |
Why?
|
| Chromatography, Paper | 4 | 1974 | 76 | 0.030 |
Why?
|
| Washington | 1 | 2013 | 314 | 0.030 |
Why?
|
| Health Maintenance Organizations | 1 | 1995 | 658 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1993 | 149 | 0.030 |
Why?
|
| Binding Sites | 2 | 2000 | 5988 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1996 | 662 | 0.030 |
Why?
|
| Base Sequence | 3 | 1998 | 12404 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 1999 | 1984 | 0.030 |
Why?
|
| Water Deprivation | 1 | 1992 | 19 | 0.030 |
Why?
|
| Data Collection | 1 | 2021 | 3320 | 0.020 |
Why?
|
| Sample Size | 1 | 2015 | 843 | 0.020 |
Why?
|
| Protein Binding | 3 | 2000 | 9297 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 1994 | 282 | 0.020 |
Why?
|
| Relaxation Therapy | 1 | 2013 | 181 | 0.020 |
Why?
|
| Probability | 1 | 1997 | 2478 | 0.020 |
Why?
|
| Medicine, Traditional | 1 | 1972 | 88 | 0.020 |
Why?
|
| Sinoatrial Node | 1 | 1992 | 99 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 6067 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 1998 | 1385 | 0.020 |
Why?
|
| Sterols | 1 | 1971 | 64 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1168 | 0.020 |
Why?
|
| Obesity | 2 | 1993 | 12940 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2217 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1997 | 8164 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2015 | 545 | 0.020 |
Why?
|
| Clofibrate | 1 | 1990 | 4 | 0.020 |
Why?
|
| Benzoflavones | 1 | 1990 | 7 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 1992 | 333 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2013 | 576 | 0.020 |
Why?
|
| Retina | 1 | 1982 | 2656 | 0.020 |
Why?
|
| Ascorbic Acid | 3 | 1985 | 654 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1973 | 554 | 0.020 |
Why?
|
| Patient Selection | 2 | 2015 | 4246 | 0.020 |
Why?
|
| Proteome | 1 | 2000 | 1856 | 0.020 |
Why?
|
| Colon | 1 | 1999 | 1791 | 0.020 |
Why?
|
| Reproduction | 2 | 1984 | 646 | 0.020 |
Why?
|
| Dopamine | 3 | 1978 | 1601 | 0.020 |
Why?
|
| Vomiting | 1 | 1994 | 650 | 0.020 |
Why?
|
| Cytochrome Reductases | 1 | 1990 | 9 | 0.020 |
Why?
|
| Social Behavior Disorders | 1 | 1990 | 96 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12052 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 1995 | 1240 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 1996 | 2091 | 0.020 |
Why?
|
| Health Behavior | 1 | 2001 | 2641 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 1999 | 4822 | 0.020 |
Why?
|
| Personality Tests | 1 | 1989 | 80 | 0.020 |
Why?
|
| Phenobarbital | 1 | 1990 | 191 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2015 | 708 | 0.020 |
Why?
|
| Infertility, Female | 3 | 1971 | 761 | 0.020 |
Why?
|
| Alopecia | 1 | 1994 | 412 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1998 | 2119 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2003 | 1936 | 0.020 |
Why?
|
| Proadifen | 2 | 1987 | 11 | 0.020 |
Why?
|
| Seminal Vesicles | 3 | 1981 | 103 | 0.020 |
Why?
|
| Arginine | 1 | 1993 | 920 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2012 | 991 | 0.020 |
Why?
|
| Oxytocin | 1 | 1993 | 402 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 1992 | 519 | 0.020 |
Why?
|
| Isoniazid | 1 | 1990 | 283 | 0.020 |
Why?
|
| Methods | 2 | 1982 | 1063 | 0.020 |
Why?
|
| Dexamethasone | 2 | 2000 | 1945 | 0.020 |
Why?
|
| Psychiatric Department, Hospital | 1 | 1989 | 125 | 0.020 |
Why?
|
| Prisons | 1 | 1990 | 174 | 0.020 |
Why?
|
| Crystallography | 1 | 1988 | 114 | 0.020 |
Why?
|
| Substrate Specificity | 3 | 1995 | 1768 | 0.020 |
Why?
|
| Graft Survival | 1 | 1999 | 3843 | 0.020 |
Why?
|
| Wakefulness | 1 | 1995 | 1264 | 0.020 |
Why?
|
| Naltrexone | 1 | 1990 | 317 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4513 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 1988 | 289 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1989 | 350 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4935 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 1401 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2013 | 990 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2008 | 301 | 0.020 |
Why?
|
| Nitriles | 1 | 1992 | 971 | 0.020 |
Why?
|
| Catechols | 1 | 1987 | 62 | 0.020 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 1986 | 38 | 0.020 |
Why?
|
| Quinones | 1 | 1986 | 78 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1986 | 149 | 0.020 |
Why?
|
| DNA | 1 | 2000 | 7189 | 0.020 |
Why?
|
| Benzene Derivatives | 1 | 1986 | 51 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2002 | 6635 | 0.020 |
Why?
|
| Theca Cells | 1 | 1986 | 15 | 0.020 |
Why?
|
| Bacteria, Anaerobic | 1 | 1986 | 70 | 0.020 |
Why?
|
| Medical Records | 1 | 2012 | 1409 | 0.020 |
Why?
|
| Uterus | 2 | 1982 | 651 | 0.020 |
Why?
|
| Ovariectomy | 1 | 1989 | 614 | 0.020 |
Why?
|
| Jamaica | 3 | 1992 | 54 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1986 | 294 | 0.020 |
Why?
|
| Discrimination Learning | 2 | 1999 | 278 | 0.020 |
Why?
|
| Stomach Ulcer | 2 | 1957 | 122 | 0.020 |
Why?
|
| Sodium Azide | 2 | 1995 | 24 | 0.020 |
Why?
|
| Imidazoles | 1 | 1992 | 1172 | 0.020 |
Why?
|
| Hostility | 1 | 2007 | 183 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 1878 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 1998 | 1920 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1996 | 1812 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2003 | 54437 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1994 | 1818 | 0.020 |
Why?
|
| Catecholamines | 1 | 1987 | 387 | 0.020 |
Why?
|
| Incidence | 2 | 1995 | 21366 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2003 | 11512 | 0.020 |
Why?
|
| Azides | 2 | 1995 | 118 | 0.020 |
Why?
|
| Child Welfare | 1 | 2010 | 521 | 0.020 |
Why?
|
| Counseling | 1 | 2013 | 1536 | 0.020 |
Why?
|
| Hypophysectomy | 2 | 1977 | 114 | 0.020 |
Why?
|
| Models, Molecular | 2 | 1988 | 5406 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2003 | 6345 | 0.020 |
Why?
|
| Plasma Cells | 2 | 2000 | 597 | 0.020 |
Why?
|
| Apoptosis | 2 | 2000 | 9478 | 0.020 |
Why?
|
| Ouabain | 1 | 1985 | 246 | 0.020 |
Why?
|
| Amygdala | 3 | 1982 | 1353 | 0.020 |
Why?
|
| Steroids | 1 | 1970 | 929 | 0.020 |
Why?
|
| Ovarian Diseases | 2 | 1966 | 137 | 0.020 |
Why?
|
| Social Support | 1 | 2015 | 2175 | 0.020 |
Why?
|
| Peptic Ulcer | 2 | 1957 | 216 | 0.020 |
Why?
|
| Receptors, Cell Surface | 2 | 1989 | 2802 | 0.020 |
Why?
|
| Trypsin | 1 | 1986 | 486 | 0.020 |
Why?
|
| Urban Health | 1 | 1987 | 532 | 0.020 |
Why?
|
| Organ Size | 4 | 1981 | 2253 | 0.020 |
Why?
|
| Methylation | 3 | 1990 | 1070 | 0.010 |
Why?
|
| Random Allocation | 1 | 1989 | 2393 | 0.010 |
Why?
|
| Body Mass Index | 2 | 1993 | 12952 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1993 | 2137 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1996 | 3048 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2000 | 7851 | 0.010 |
Why?
|
| Alpha Rhythm | 1 | 2004 | 111 | 0.010 |
Why?
|
| Mice | 3 | 2000 | 81330 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3418 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 2293 | 0.010 |
Why?
|
| Multiple Myeloma | 2 | 2000 | 5145 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1995 | 2642 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1988 | 1147 | 0.010 |
Why?
|
| Recurrence | 3 | 2003 | 8457 | 0.010 |
Why?
|
| Communication | 1 | 1997 | 3872 | 0.010 |
Why?
|
| Philadelphia | 1 | 2003 | 267 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 1998 | 5301 | 0.010 |
Why?
|
| Butanols | 1 | 2002 | 19 | 0.010 |
Why?
|
| Psychiatry | 1 | 2015 | 1699 | 0.010 |
Why?
|
| Pregnenolone | 3 | 1971 | 27 | 0.010 |
Why?
|
| Receptors, Opioid | 1 | 1983 | 145 | 0.010 |
Why?
|
| Cattle | 2 | 1978 | 3818 | 0.010 |
Why?
|
| Theta Rhythm | 1 | 2004 | 219 | 0.010 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1984 | 239 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 1762 | 0.010 |
Why?
|
| Neuroblastoma | 2 | 1982 | 1246 | 0.010 |
Why?
|
| Semantics | 1 | 1985 | 612 | 0.010 |
Why?
|
| Blotting, Western | 2 | 2000 | 5032 | 0.010 |
Why?
|
| Receptors, Estrogen | 2 | 1996 | 2208 | 0.010 |
Why?
|
| Social Behavior | 2 | 1999 | 1136 | 0.010 |
Why?
|
| Sertoli Cells | 1 | 1981 | 50 | 0.010 |
Why?
|
| Cysts | 2 | 1966 | 680 | 0.010 |
Why?
|
| Carcinogens | 2 | 1996 | 452 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2004 | 1262 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 3 | 1971 | 213 | 0.010 |
Why?
|
| Veins | 4 | 1973 | 767 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 2 | 1994 | 547 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 1982 | 272 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2697 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 2 | 1990 | 318 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2000 | 336 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1984 | 959 | 0.010 |
Why?
|
| Limbic System | 1 | 1983 | 419 | 0.010 |
Why?
|
| Lung | 1 | 1979 | 9979 | 0.010 |
Why?
|
| Detergents | 1 | 2000 | 235 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 4310 | 0.010 |
Why?
|
| Densitometry | 1 | 1980 | 151 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1993 | 4404 | 0.010 |
Why?
|
| Bacterial Infections | 2 | 1986 | 1390 | 0.010 |
Why?
|
| Choroiditis | 1 | 1999 | 12 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1998 | 3803 | 0.010 |
Why?
|
| Health Surveys | 1 | 2010 | 4037 | 0.010 |
Why?
|
| Retinitis | 1 | 1999 | 36 | 0.010 |
Why?
|
| Aminopeptidases | 1 | 1980 | 95 | 0.010 |
Why?
|
| Saliva | 2 | 1994 | 828 | 0.010 |
Why?
|
| Aminopyrine N-Demethylase | 1 | 1979 | 1 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 283 | 0.010 |
Why?
|
| Membranes | 1 | 1979 | 164 | 0.010 |
Why?
|
| Citric Acid | 1 | 1999 | 123 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 282 | 0.010 |
Why?
|
| Choroid Diseases | 1 | 1999 | 63 | 0.010 |
Why?
|
| Sleep | 1 | 1995 | 4759 | 0.010 |
Why?
|
| Tissue Preservation | 1 | 1999 | 174 | 0.010 |
Why?
|
| Disorders of Sex Development | 1 | 1980 | 128 | 0.010 |
Why?
|
| Ectoparasitic Infestations | 1 | 1998 | 12 | 0.010 |
Why?
|
| Cell Line | 3 | 2000 | 15545 | 0.010 |
Why?
|
| Melphalan | 1 | 2000 | 420 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1998 | 66 | 0.010 |
Why?
|
| Placenta | 1 | 1988 | 1711 | 0.010 |
Why?
|
| Species Specificity | 1 | 1983 | 2406 | 0.010 |
Why?
|
| Haplorhini | 1 | 1979 | 523 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13249 | 0.010 |
Why?
|
| Carbon Monoxide | 2 | 1979 | 547 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 924 | 0.010 |
Why?
|
| Self Mutilation | 1 | 1998 | 57 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1978 | 292 | 0.010 |
Why?
|
| Acetates | 1 | 1999 | 319 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1990 | 10088 | 0.010 |
Why?
|
| Permeability | 1 | 1980 | 721 | 0.010 |
Why?
|
| Leukemia, Plasma Cell | 1 | 1998 | 46 | 0.010 |
Why?
|
| Oxides | 1 | 1999 | 401 | 0.010 |
Why?
|
| Vincristine | 1 | 2000 | 1036 | 0.010 |
Why?
|
| Biological Assay | 2 | 1979 | 623 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1991 | 6387 | 0.010 |
Why?
|
| Health Policy | 1 | 2010 | 2679 | 0.010 |
Why?
|
| Chromatography, Gas | 2 | 1994 | 150 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 1999 | 58952 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1978 | 390 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 2 | 1968 | 145 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1518 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 1998 | 255 | 0.010 |
Why?
|
| Dimethylnitrosamine | 1 | 1996 | 17 | 0.010 |
Why?
|
| Neurotic Disorders | 1 | 1956 | 77 | 0.010 |
Why?
|
| Mycobacterium avium Complex | 1 | 1996 | 60 | 0.010 |
Why?
|
| Ethynodiol Diacetate | 2 | 1973 | 3 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1996 | 100 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 1977 | 257 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2175 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1968 | 410 | 0.010 |
Why?
|
| Sulfadiazine | 1 | 1996 | 18 | 0.010 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1996 | 76 | 0.010 |
Why?
|
| Gonadotropins, Pituitary | 2 | 1966 | 69 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1998 | 1059 | 0.010 |
Why?
|
| Medroxyprogesterone | 2 | 1973 | 35 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1998 | 410 | 0.010 |
Why?
|
| Stanford-Binet Test | 1 | 1975 | 3 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1999 | 773 | 0.010 |
Why?
|
| Chorioretinitis | 1 | 1996 | 43 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1996 | 136 | 0.010 |
Why?
|
| Myocardium | 1 | 1989 | 4746 | 0.010 |
Why?
|
| Pyrimethamine | 1 | 1996 | 94 | 0.010 |
Why?
|
| Orotic Acid | 1 | 1975 | 24 | 0.010 |
Why?
|
| Prednisone | 1 | 2000 | 1565 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 542 | 0.010 |
Why?
|
| Vasculitis | 1 | 1999 | 522 | 0.010 |
Why?
|
| Rodent Diseases | 1 | 1975 | 52 | 0.010 |
Why?
|
| Boston | 1 | 2008 | 9327 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1975 | 184 | 0.010 |
Why?
|
| Androstenediols | 1 | 1974 | 1 | 0.010 |
Why?
|
| Eye Injuries | 1 | 1998 | 227 | 0.010 |
Why?
|
| Steroid 16-alpha-Hydroxylase | 1 | 1994 | 12 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4167 | 0.010 |
Why?
|
| Necrosis | 1 | 1999 | 1610 | 0.010 |
Why?
|
| Antidotes | 1 | 1996 | 138 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1977 | 629 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2003 | 41496 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1981 | 1116 | 0.010 |
Why?
|
| Pain Threshold | 1 | 1999 | 603 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 1996 | 251 | 0.010 |
Why?
|
| Toxoplasma | 1 | 1996 | 158 | 0.010 |
Why?
|
| Prostate | 2 | 1981 | 1772 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 1545 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1974 | 398 | 0.010 |
Why?
|
| Racemases and Epimerases | 1 | 1975 | 114 | 0.010 |
Why?
|
| Vitreous Body | 1 | 1996 | 399 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1977 | 10756 | 0.010 |
Why?
|
| Mestranol | 1 | 1973 | 8 | 0.010 |
Why?
|
| Leucovorin | 1 | 1996 | 643 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1996 | 426 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 1996 | 7407 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 1999 | 854 | 0.010 |
Why?
|
| Lead | 1 | 1999 | 879 | 0.010 |
Why?
|
| Cicatrix | 1 | 1999 | 793 | 0.010 |
Why?
|
| Supraoptic Nucleus | 1 | 1993 | 28 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2000 | 2224 | 0.010 |
Why?
|
| Iproniazid | 1 | 1973 | 8 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1993 | 108 | 0.010 |
Why?
|
| Nialamide | 1 | 1973 | 5 | 0.010 |
Why?
|
| Reserpine | 1 | 1973 | 63 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1999 | 705 | 0.010 |
Why?
|
| Epididymis | 1 | 1975 | 227 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1973 | 74 | 0.010 |
Why?
|
| Proteins | 2 | 1985 | 5993 | 0.010 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1993 | 113 | 0.010 |
Why?
|
| Perfusion | 1 | 1977 | 1390 | 0.010 |
Why?
|
| Superstitions | 1 | 1972 | 3 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1983 | 2189 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1993 | 260 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 4451 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1977 | 1963 | 0.010 |
Why?
|
| Ceremonial Behavior | 1 | 1972 | 17 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1996 | 896 | 0.010 |
Why?
|
| Africa, Eastern | 1 | 1972 | 76 | 0.010 |
Why?
|
| Serotonin | 1 | 1977 | 1042 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 2 | 1971 | 258 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1900 | 0.010 |
Why?
|
| Philosophy, Medical | 1 | 1972 | 79 | 0.010 |
Why?
|
| Menstruation | 2 | 1971 | 307 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 3726 | 0.010 |
Why?
|
| Premenopause | 1 | 1996 | 1039 | 0.010 |
Why?
|
| Carcinoma, Lobular | 1 | 1996 | 480 | 0.010 |
Why?
|
| DNA Primers | 1 | 1996 | 2814 | 0.010 |
Why?
|
| Self-Injurious Behavior | 1 | 1998 | 566 | 0.010 |
Why?
|
| Melatonin | 1 | 1977 | 668 | 0.010 |
Why?
|
| Punctures | 1 | 1973 | 366 | 0.010 |
Why?
|
| Vasopressins | 1 | 1993 | 351 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1973 | 346 | 0.010 |
Why?
|
| Dydrogesterone | 1 | 1971 | 1 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 1996 | 1129 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1995 | 20588 | 0.010 |
Why?
|
| Hydroxyprogesterones | 1 | 1971 | 24 | 0.010 |
Why?
|
| beta-Naphthoflavone | 1 | 1990 | 5 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1994 | 13632 | 0.010 |
Why?
|
| Pregnanediol | 1 | 1970 | 18 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1973 | 392 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1973 | 683 | 0.010 |
Why?
|
| Corpus Luteum | 1 | 1970 | 81 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1998 | 2410 | 0.010 |
Why?
|
| Phytotherapy | 1 | 1972 | 296 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6125 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2000 | 2911 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3696 | 0.010 |
Why?
|
| Free Radicals | 1 | 1990 | 238 | 0.010 |
Why?
|
| Fallopian Tubes | 1 | 1970 | 178 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2000 | 6819 | 0.010 |
Why?
|
| Buffers | 1 | 1989 | 143 | 0.010 |
Why?
|
| Radiochemistry | 1 | 1989 | 49 | 0.010 |
Why?
|
| Sulfates | 1 | 1970 | 378 | 0.010 |
Why?
|
| Bacteremia | 1 | 1996 | 978 | 0.010 |
Why?
|
| Epinephrine | 1 | 1973 | 791 | 0.010 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 1989 | 43 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1984 | 8479 | 0.000 |
Why?
|
| Catheterization | 1 | 1974 | 1428 | 0.000 |
Why?
|
| Superoxides | 1 | 1990 | 388 | 0.000 |
Why?
|
| Up-Regulation | 1 | 1998 | 4111 | 0.000 |
Why?
|
| Body Weight | 2 | 1981 | 4618 | 0.000 |
Why?
|
| Anti-Infective Agents | 1 | 1996 | 983 | 0.000 |
Why?
|
| Biopsy | 1 | 2000 | 6781 | 0.000 |
Why?
|
| Uganda | 1 | 1973 | 1332 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2000 | 11733 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1996 | 1450 | 0.000 |
Why?
|
| Autoradiography | 1 | 1989 | 730 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1971 | 1498 | 0.000 |
Why?
|
| Opioid-Related Disorders | 1 | 1983 | 2164 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2001 | 12341 | 0.000 |
Why?
|
| Fetal Heart | 1 | 1989 | 281 | 0.000 |
Why?
|
| Disease | 1 | 1972 | 670 | 0.000 |
Why?
|
| Mixed Function Oxygenases | 1 | 1987 | 265 | 0.000 |
Why?
|
| Bacillus | 1 | 1986 | 77 | 0.000 |
Why?
|
| Ileum | 1 | 1989 | 557 | 0.000 |
Why?
|
| Endocrine Glands | 1 | 1966 | 101 | 0.000 |
Why?
|
| Health Education | 1 | 1972 | 1049 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 8998 | 0.000 |
Why?
|
| Litter Size | 1 | 1984 | 49 | 0.000 |
Why?
|
| Rats, Inbred WKY | 1 | 1984 | 150 | 0.000 |
Why?
|
| Hypertension | 1 | 1984 | 8536 | 0.000 |
Why?
|
| Medicine | 1 | 1972 | 942 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1973 | 4138 | 0.000 |
Why?
|
| Sexual Maturation | 1 | 1984 | 261 | 0.000 |
Why?
|
| Fetal Death | 1 | 1984 | 435 | 0.000 |
Why?
|
| Language | 1 | 1972 | 1539 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1994 | 2569 | 0.000 |
Why?
|
| Lipids | 1 | 1973 | 3331 | 0.000 |
Why?
|
| Antibodies | 1 | 1990 | 2415 | 0.000 |
Why?
|
| Contraception | 1 | 1966 | 347 | 0.000 |
Why?
|
| Androgen-Binding Protein | 1 | 1981 | 10 | 0.000 |
Why?
|
| Antioxidants | 1 | 1989 | 1667 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2003 | 24022 | 0.000 |
Why?
|
| Neoplasms | 1 | 1990 | 22142 | 0.000 |
Why?
|
| Aging | 1 | 1980 | 8702 | 0.000 |
Why?
|
| Hexobarbital | 1 | 1979 | 3 | 0.000 |
Why?
|
| Benzopyrenes | 1 | 1979 | 5 | 0.000 |
Why?
|
| Meperidine | 1 | 1979 | 38 | 0.000 |
Why?
|
| Chorionic Gonadotropin | 1 | 1981 | 457 | 0.000 |
Why?
|
| Pyrogallol | 1 | 1978 | 8 | 0.000 |
Why?
|
| Pseudopregnancy | 1 | 1978 | 10 | 0.000 |
Why?
|
| Rete Testis | 1 | 1977 | 10 | 0.000 |
Why?
|
| Decidua | 1 | 1978 | 82 | 0.000 |
Why?
|
| Body Fluids | 1 | 1977 | 320 | 0.000 |
Why?
|
| Aniline Compounds | 1 | 1979 | 1073 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1971 | 458 | 0.000 |
Why?
|
| Chlormadinone Acetate | 1 | 1969 | 1 | 0.000 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1968 | 88 | 0.000 |
Why?
|
| Chemosterilants | 1 | 1966 | 1 | 0.000 |
Why?
|
| Tetrazolium Salts | 1 | 1966 | 92 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1981 | 6392 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1984 | 18222 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1973 | 80675 | 0.000 |
Why?
|
| Light | 1 | 1968 | 1348 | 0.000 |
Why?
|